GVOKE PFS FDA approval date
The FDA approved GVOKE PFS on 10 Sep 2019.
- FDA approval date
- 10 Sep 2019
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as GLUCAGON
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2019-09-10Day | GVOKE PFS | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA212097", "applicant_as_listed_by_fda": "XERIS", "brand_names": ["GVOKE HYPOPEN", "GVOKE KIT", "GVOKE PFS", "GVOKE VIALDX"], "active_ingredients": ["GLUCAGON"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20190910", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |